Clinical trial

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary…

NCT00485433 · Pacira Pharmaceuticals, Inc, Industry · Completed

Key facts

NCT number NCT00485433
Title Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair
Official title A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair.
Lead sponsor Pacira Pharmaceuticals, Inc, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Postoperative Pain
Intervention type Drug
Interventions Bupivacaine HCl, SKY0402
Enrollment 98
Start date Jun 1, 2007
Primary completion Dec 1, 2007
Completion Aug 1, 2008
First posted Jun 13, 2007
Last update posted Mar 2, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies